Properties (61)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
Eisai's_oncology_business
|
| gptkbp:areaServed |
Europe
|
| gptkbp:CEO |
gptkb:Jochen_W._W._Schmitt
|
| gptkbp:clinicalTrials |
multiple ongoing clinical trials
conducts Phase I to Phase III trials focuses on patient-centric trials has a diverse clinical trial portfolio has a robust pipeline conducts_clinical_research_in_Europe conducts_trials_across_Europe |
| gptkbp:collaborations |
academic institutions
|
| gptkbp:community_service |
improves healthcare access
|
| gptkbp:communityEngagement |
engages with local communities
|
| gptkbp:corporateSocialResponsibility |
committed to CSR initiatives
|
| gptkbp:culturalHeritage |
promotes diversity and inclusion
|
| gptkbp:employees |
over 1,000
|
| gptkbp:focus |
research and development
|
| gptkbp:founded |
2005
|
| gptkbp:globalPresence |
operates in multiple countries
|
| gptkbp:hasResearchInterest |
conducts market research
|
| gptkbp:headquarters |
gptkb:Munich,_Germany
|
| gptkbp:healthcare |
focuses on patient care initiatives
|
| https://www.w3.org/2000/01/rdf-schema#label |
Daiichi Sankyo Europe GmbH
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:innovation |
focuses on innovative drug development
|
| gptkbp:investmentFocus |
invests in R&D
|
| gptkbp:market |
launches new products regularly
European_market |
| gptkbp:marketSegment |
focuses on specialty pharmaceuticals
|
| gptkbp:mission |
improving patient outcomes
|
| gptkbp:parentCompany |
gptkb:Daiichi_Sankyo_Company,_Limited
|
| gptkbp:partnerships |
gptkb:AstraZeneca
collaborates with healthcare professionals engages in strategic partnerships partners with healthcare organizations works with regulatory agencies collaborates with biotech companies collaborates with patient advocacy groups |
| gptkbp:philanthropy |
supports health-related charities
|
| gptkbp:products |
vaccines
oncology drugs cardiovascular drugs focuses on product development |
| gptkbp:regulatoryCompliance |
ensures compliance with regulations
various_European_countries |
| gptkbp:research |
provides funding for research projects
|
| gptkbp:research_areas |
cardiology
oncology immunology |
| gptkbp:researchFocus |
targeted therapies
biologics small molecules |
| gptkbp:researchInterest |
engages in research collaborations
drives research innovation |
| gptkbp:subsidiary |
gptkb:Daiichi_Sankyo_Company,_Limited
|
| gptkbp:supplyChain |
maintains a robust supply chain
|
| gptkbp:sustainabilityInitiatives |
committed to sustainability
|
| gptkbp:training |
provides training programs
|
| gptkbp:vision |
be a leader in innovative medicines
|
| gptkbp:website |
www.daiichisankyo.eu
|